Abstract

We reviewed confirmed cases of pediatric invasive meningococcal disease in Tijuana, Mexico, and San Diego County, California, USA, during 2005–2008. The overall incidence and fatality rate observed in Tijuana were similar to those found in the US, and serogroup distribution suggests that most cases in Tijuana are vaccine preventable.

Highlights

  • Physicians in Mexico at the US–Mexico border areas often encounter patients with symptoms highly compatible with Invasive meningococcal disease (IMD), diagnosis is not routinely culture-confirmed; this likely leads to underreporting

  • Data on all pediatric IMD reported to the San Diego County (SDC) Health and Human Services Agency through electronic laboratory notification or from infection control practitioners were retrospectively analyzed during the same period

  • A significant difference in serogroup was observed by site: serogroup C was most commonly identified at Tijuana General Hospital (TGH) (62.5%), whereas serogroup B was most common in SDC (61.5%) (Figure 2) (p = 0.005)

Read more

Summary

Surveillance for Invasive Meningococcal

We reviewed confirmed cases of pediatric invasive meningococcal disease in Tijuana, Mexico, and San Diego County, California, USA, during 2005–2008. The goals of our study were to compare hospital-based estimates of IMD in children and serogroup distribution at Tijuana General Hospital (TGH), Mexico, with a catchment population of nearly 200,000 children

Not typed
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.